Results 1 to 10 of about 3,974 (218)

Efficacy and safety of small molecule drugs in the treatment of pityriasis rubra pilaris—A systematic review [PDF]

open access: yesFrontiers in Medicine
BackgroundPityriasis rubra pilaris is a chronic, scaly, keratotic skin disease, mainly manifested as scaly plaques and keratinized hair follicles. This condition significantly impacts the patient’s quality of life and is considered one of the intractable
Xiaofang Zhang   +7 more
doaj   +5 more sources

Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris [PDF]

open access: goldCase Reports in Dermatology, 2011
Treatment of pityriasis rubra pilaris is still challenging. We here present a 74-year-old woman who had not experienced stable remission of her skin symptoms during prior treatments including topical and systemic corticosteroids, phototherapy, orally ...
Laurenz Schmitt   +2 more
doaj   +6 more sources

Tofacitinib for Pityriasis Rubra Pilaris: A Case Report [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Hongyan Tan, Bin Zhang, Xiawei Kang, Lvyao Wang, Xiao Qiu, Xiangyu Hu Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, 400011, People’s Republic of ChinaCorrespondence: Xiangyu Hu, Email 369930758@qq.comPurpose ...
Tan H   +5 more
doaj   +5 more sources

Juvenile Pityriasis Rubra Pilaris [PDF]

open access: yesDermatology Practical & Conceptual, 2023
Yihang Xie   +3 more
doaj   +4 more sources

Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab [PDF]

open access: goldCase Reports in Dermatology, 2018
Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to ...
Kathrin Hanfstingl   +4 more
doaj   +2 more sources

Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report [PDF]

open access: yesSAGE Open Medical Case Reports, 2023
Pityriasis rubra pilaris is a rare inflammatory dermatosis characterized by orange-red confluent plaques, hyperkeratotic follicular papules, palmoplantar keratoderma, and, in some cases, erythroderma.
Mysa Saad, Alison Spurr, Jennifer Lipson
doaj   +2 more sources

Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris [PDF]

open access: yesClinical Case Reports, 2022
A man with pityriasis rubra pilaris (PRP) showed no improvement in skin symptoms despite treatment with several drugs. The patient was diagnosed as having type 1 PRP. Combination therapy with cyclosporine and guselkumab improved his skin condition. Here,
Mai Nishimura   +4 more
doaj   +2 more sources

Pityriasis Rubra Pilaris [PDF]

open access: bronzeProceedings of the Royal Society of Medicine, 1928
E. G. Graham Little
openalex   +5 more sources

A case of pityriasis rubra pilaris secondary to ponatinib [PDF]

open access: yesSAGE Open Medical Case Reports
Ponatinib, a tyrosine kinase inhibitor used for chronic myeloid leukemia and acute lymphoblastic leukemia, can cause rare cutaneous side effects. In this case, a 63-year-old woman developed a pityriasis rubra pilaris-like eruption 1 month after starting ...
Ariana Nateghi   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy